U.S., Feb. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07433569) titled 'A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma' on Feb. 20.
Brief Summary: The purpose of this study is to assess the pharmacokinetics (PK) and safety of symbicort aerosphere and symbicort pressurized metered dose inhaler (pMDI) in participants with asthma aged 4 to less than 12 years.
Study Start Date: March 06
Study Type: INTERVENTIONAL
Condition:
Asthma
Intervention:
COMBINATION_PRODUCT: Budesonide/formoterol fumarate Aerosphere
Participants will receive budesonide/formoterol fum...